ProStrakan Announces NewBridge Pharmaceuticals as Partner for Sancuso in the Middle East and Africa - 6/11/2008
Click to read more
ProStrakan and Orexo Extend Licensing Agreement for Rapinyl/Abstral to include North America - 31/7/2008
Click to read more
Testosterone replacement study shows positive results in diabetic men from 2% testosterone gel - 18/6/2008
Click to read more
ProStrakan and JapanBridge Partner to Develop Sancuso in Japan, China & Parts of SE Asia - 23/5/2008
Click to read more
ProStrakan announces Torrex Chiesi as partner for Xomolix in Austria and CEE - 19/5/2008
Click to read more
ProStrakan announces positive results from pivotal US "Fortify" study on Fortigel (testosterone 2% gel) - 8/5/2008
Click to read more
Xomolix Receives Additional Key European Approvals - 2/4/2008
Click here for full releaseClick to read more
ProStrakan Reports Further Progress in a Year of Significant Developments - 13/3/2008
Click to download press release